3rd Quarter - Report — ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP (2010)

Firm

ASTRAZENECA PHARMACEUTICALS LP

Client

ASTRAZENECA PHARMACEUTICALS LP

Income

—

Expenses

$1,460,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Patent issues associated with anti-biotics (currently unassigned)

Lobbyist	Covered position, as disclosed
ANN BLACKWOOD	—
RICHARD BUCKLEY	—
WAYNE PALMER	—
BRADLEY ALLEN ROSSIN New	Leg. Assistant to Rep. Brian Bilbray 1997-2001

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 4899 (111th), S. 3677 (111th)

Pharmacy PHA

FDA Appropriations issues, including issues likely to incorporated into the Prescription Drug User Fee Act (PDUFA) V (currently unassigned)

Lobbyist	Covered position, as disclosed
ANDREW KAPLAN	—
WAYNE PALMER	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology

Lobbyist	Covered position, as disclosed
MELISSA BARTLETT New	Intern, Rep. Bunning/Sen. McConnell 1995
CHRISTINE BLOOMQUIST	—
DANNY LY	Leg. Assistant to Rep. Earl Blumenauer 2003-07
BRADLEY ALLEN ROSSIN New	Leg. Assistant to Rep. Brian Bilbray 1997-2001

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3590 (111th), H.R. 4872 (111th)

Consumer Issues/Safety/Products CSP

Legislative proposals regarding prescription drug importation and safety issues

Lobbyist	Covered position, as disclosed
BRADLEY ALLEN ROSSIN New	Leg. Assistant to Rep. Brian Bilbray 1997-2001

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap program 340B Drug Pricing program issues (currently unassigned), including program expansion

Lobbyist	Covered position, as disclosed
CHRISTINE BLOOMQUIST	—
DANNY LY	Leg. Assistant to Rep. Earl Blumenauer 2003-07
RICHARD WAYNE OLSON	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4872 (111th), H.R. 3590 (111th)

Government Issues GOV

HR 5175, S 3295, S 3628 - legislative proposals related to campaign finance issues

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	—
ANDREW KAPLAN	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5175 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.